Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial cell dysfunction: the syndrome in making.

Edmond O'Riordan1, Jun Chen, Sergey V Brodsky

  • 1Division of Nephrology and Renal Research Institute, Department of Medicine, New York Medical College, Valhalla, New York 10595, USA.

Kidney International
|April 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifting Sands or ANCA-ed in Place? The Epidemiology of ANCA-Associated Vasculitis over 2 Decades at a Large Tertiary Centre.

Glomerular diseases·2025
Same author

ANCA-negative granulomatosis polyangiitis: an airway emergency.

BMJ case reports·2024
Same author

Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy-Experience from a Single Tertiary Centre.

Vaccines·2022
Same author

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance.

Vaccines·2022
Same author

Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients.

Nephron·2021
Same author

Safely reducing haemodialysis frequency during the COVID-19 pandemic.

BMC nephrology·2020
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Endothelial cell dysfunction underlies cardiovascular diseases and kidney disease complications. This study explores molecular causes like hyperhomocysteinemia, ADMA, and AGEs, proposing a model for this complex condition.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Molecular Biology

Background:

  • Endothelial cell dysfunction is a key factor in cardiovascular diseases and complications of chronic kidney disease.
  • The precise definition, pathophysiology, and therapeutic strategies for this condition remain unclear.

Purpose of the Study:

  • To summarize molecular mechanisms contributing to endothelial dysfunction.
  • To propose a model for endothelial dysfunction based on interconnected cellular functions.

Main Methods:

  • Literature review and synthesis of molecular mechanisms.
  • Development of a conceptual model for endothelial dysfunction.

Main Results:

  • Hyperhomocysteinemia, elevated asymmetric dimethylarginine (ADMA), and advanced glycation end products (AGEs)-modified proteins contribute to an atherogenic endothelial phenotype.

Related Experiment Videos

  • A model illustrating the interconnectedness of diverse endothelial functions in dysfunction is presented.

    • Conclusions:

    • Understanding the molecular underpinnings of endothelial dysfunction is crucial for managing cardiovascular and renal diseases.
    • Further research is needed to define and treat this syndrome effectively.